11:14 AM EDT, 05/28/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending slightly lower late Thursday morning, declining 0.1% to 1,873.2 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo ( CRTO ) and medical device maker EDAP TMS ( EDAP ) , which rose 3.3% and 3.2% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and software firm SAP (SAP), which were up 2.8% and 1.2% respectively.

The decliners from continental Europe were led by telecommunications company Nokia ( NOK ) and brewing company Anheuser-Busch InBev ( BUD ) , which fell 2.5% and 1.4% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and biotech firm BioNTech (BNTX), which were down 1.1% and 0.3% respectively.

The gainers from the UK were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 43.9% and 1.5% respectively. They were followed by communications company WPP ( WPP ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which increased 0.9% and 0.3% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics ( SLN ) and insurance company Prudential (PUK), which dropped 4.2% and 2.3% respectively. They were followed by lender HSBC ( HSBC ) and biopharmaceutical company Amarin ( AMRN ) , which lost 2% and 0.6% respectively.